Drug Profile
Monatepil
Alternative Names: AD-2615; AJ-2615Latest Information Update: 14 Jun 2000
Price :
$50
*
At a glance
- Originator Dainippon Pharmaceutical
- Class Antihypertensives; Dibenzothiepins; Ischaemic heart disorder therapies; Piperazines
- Mechanism of Action Alpha 1 adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Atherosclerosis; Hypertension
Most Recent Events
- 14 Jun 2000 Discontinued-Clinical for Atherosclerosis in Japan (Unknown route)
- 14 Jun 2000 Discontinued-Preclinical for Arrhythmias in Japan (PO)
- 14 Jun 2000 Discontinued-preregistration for Angina pectoris in Japan (Unknown route)